U.S. market Closed. Opens in 19 hours 17 minutes

ARTLW | Artelo Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-08-312020-08-312019-08-312018-08-312017-08-312016-08-312015-08-312014-08-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Expenses10.29M7.44M4.69M3.21M2.34M232.79K15.24K15.27K15.27K
Selling, General & Admin5.96M4.60M2.77M2.12M1.09M232.79K509.004.27KN/A
Research & Development4.32M2.84M1.92M1.09M1.25MN/AN/AN/AN/A
Other Operating ExpensesN/AN/A1.41K31.26K290.00N/A14.73K11.00K15.27K
Operating Income-10.29M-7.44M-4.69M-3.21M-2.34M-232.79K-15.24K-15.27K-15.27K
Other Expenses / Income204.00K2.00K30.91K1.04MN/A-2.10KN/AN/AN/A
Before Tax Income-10.08M-7.44M-4.65M-2.17M-2.34M-234.89K-15.24K-15.27K-15.27K
Income Tax Expenses-209.00K-4.00K-60.41K-2.04M8.00N/AN/AN/AN/A
Net Income-9.87M-7.44M-4.65M-2.17M-2.34M-234.89K-15.24K-15.27K-15.27K
Interest Expenses5.00KN/AN/AN/AN/A2.10KN/AN/AN/A
Basic Shares Outstanding2.83M1.25M247.00K144.00K84.00KN/A6.41M3.07M3.07M
Diluted Shares Outstanding2.83M1.25M247.18K144.83K85.17KN/A6.41M3.07M3.07M
EBITDA-10.29M-7.44M-4.71M-4.22M-2.34M-232.79K-15.24K-15.27K-15.27K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-10.08M-7.44M-4.72M-4.22M-2.34M-232.79K-15.24K-15.27K-15.27K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2022-12-312021-08-312020-08-312019-08-312018-08-312017-08-312016-08-312015-08-312014-08-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙